No abstract available
Keywords:
Metastatic; Non–small cell lung cancer; PD-L1; Pembrolizumab; Stereotactic body radiotherapy.
MeSH terms
-
Aged
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / physiopathology
-
Carcinoma, Non-Small-Cell Lung / radiotherapy*
-
Combined Modality Therapy
-
Comorbidity*
-
Humans
-
Immunotherapy*
-
Lung Diseases, Interstitial*
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / physiopathology
-
Lung Neoplasms / radiotherapy*
-
Male
-
Treatment Outcome